1	4	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Medicinal	_	_	JJ	_	_	_	_	_
2	Sesquiterpenes	_	_	NNP	_	_	_	_	_


1	Sesquiterpene	_	_	NN	_	_	_	_	_
2	biosynthesis	_	_	NN	_	_	_	_	_
3	normally	_	_	RB	_	_	_	_	_
4	begins	_	_	VBZ	_	_	_	_	_
5	in	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	cytosol	_	_	NN	_	_	_	_	_
8	via	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	C15	_	_	NNP	_	_	_	_	_
11	prenyl	_	_	NN	_	_	_	_	_
12	diphosphate	_	_	NN	_	_	_	_	_
13	FDP	_	_	NN	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	which	_	_	WDT	_	_	_	_	_
16	itself	_	_	PRP	_	_	_	_	_
17	is	_	_	VBZ	_	_	_	_	_
18	derived	_	_	VBN	_	_	_	_	_
19	from	_	_	IN	_	_	_	_	_
20	mevalonic	_	_	JJ	_	_	_	_	_
21	acid	_	_	NN	_	_	_	_	_
22	and	_	_	CC	_	_	_	_	_
23	the	_	_	DT	_	_	_	_	_
24	MVA	_	_	NN	_	_	_	_	_
25	pathway	_	_	NN	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	Sesquiterpene	_	_	NN	_	_	_	_	_
2	synthases	_	_	NNS	_	_	_	_	_
3	act	_	_	VBP	_	_	_	_	_
4	on	_	_	IN	_	_	_	_	_
5	FDP	_	_	NNP	_	_	_	_	_
6	to	_	_	TO	_	_	_	_	_
7	yield	_	_	VB	_	_	_	_	_
8	hundreds	_	_	NNS	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	sesquiterpene	_	_	NN	_	_	_	_	_
11	hydrocarbons	_	_	NNS	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	alcohols	_	_	NNS	_	_	_	_	_
14	based	_	_	VBN	_	_	_	_	_
15	on	_	_	IN	_	_	_	_	_
16	dozens	_	_	NNS	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	carbon	_	_	NN	_	_	_	_	_
19	skeletons	_	_	NNS	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	They	_	_	PRP	_	_	_	_	_
2	are	_	_	VBP	_	_	_	_	_
3	frequently	_	_	RB	_	_	_	_	_
4	responsible	_	_	JJ	_	_	_	_	_
5	for	_	_	IN	_	_	_	_	_
6	familiar	_	_	JJ	_	_	_	_	_
7	scents	_	_	NNS	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	flavors	_	_	NNS	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	for	_	_	IN	_	_	_	_	_
12	instance	_	_	NN	_	_	_	_	_
13	ginger	_	_	NN	_	_	_	_	_
14	(	_	_	-LRB-	_	_	_	_	_
15	gingerol	_	_	NN	_	_	_	_	_
16	)	_	_	-RRB-	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	clove	_	_	NN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	cannabis	_	_	NN	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	rosemary	_	_	NN	_	_	_	_	_
23	(	_	_	-LRB-	_	_	_	_	_
24	β-caryophyllene	_	_	NN	_	_	_	_	_
25	)	_	_	-RRB-	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	patchouli	_	_	NN	_	_	_	_	_
28	(	_	_	-LRB-	_	_	_	_	_
29	patchoulol	_	_	NN	_	_	_	_	_
30	)	_	_	-RRB-	_	_	_	_	_
31	,	_	_	,	_	_	_	_	_
32	sandalwood	_	_	NN	_	_	_	_	_
33	(	_	_	-LRB-	_	_	_	_	_
34	α-santalene	_	_	NN	_	_	_	_	_
35	)	_	_	-RRB-	_	_	_	_	_
36	,	_	_	,	_	_	_	_	_
37	and	_	_	CC	_	_	_	_	_
38	rain	_	_	NN	_	_	_	_	_
39	(	_	_	-LRB-	_	_	_	_	_
40	geosmin	_	_	NN	_	_	_	_	_
41	,	_	_	,	_	_	_	_	_
42	a	_	_	DT	_	_	_	_	_
43	bacterial	_	_	JJ	_	_	_	_	_
44	sesquiterpene	_	_	NN	_	_	_	_	_
45	)	_	_	-RRB-	_	_	_	_	_
46	.	_	_	.	_	_	_	_	_


1	They	_	_	PRP	_	_	_	_	_
2	are	_	_	VBP	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	heaviest	_	_	JJS	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	volatile	_	_	JJ	_	_	_	_	_
8	terpenes	_	_	NNS	_	_	_	_	_
9	under	_	_	IN	_	_	_	_	_
10	standard	_	_	JJ	_	_	_	_	_
11	conditions	_	_	NNS	_	_	_	_	_
12	(	_	_	-LRB-	_	_	_	_	_
13	diterpene	_	_	NN	_	_	_	_	_
14	hydrocarbons	_	_	NNS	_	_	_	_	_
15	ordinarily	_	_	RB	_	_	_	_	_
16	require	_	_	VBP	_	_	_	_	_
17	heating	_	_	NN	_	_	_	_	_
18	to	_	_	TO	_	_	_	_	_
19	form	_	_	VB	_	_	_	_	_
20	gases	_	_	NNS	_	_	_	_	_
21	)	_	_	-RRB-	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	Plant	_	_	NN	_	_	_	_	_
2	families	_	_	NNS	_	_	_	_	_
3	known	_	_	VBN	_	_	_	_	_
4	to	_	_	TO	_	_	_	_	_
5	be	_	_	VB	_	_	_	_	_
6	principal	_	_	JJ	_	_	_	_	_
7	producers	_	_	NNS	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	sesquiterpene	_	_	NN	_	_	_	_	_
10	volatiles	_	_	NNS	_	_	_	_	_
11	include	_	_	VBP	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	Lamiaceae	_	_	NNP	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	Geraniaceae	_	_	NNP	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	Rutaceae	_	_	NNP	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	Myrtaceae	_	_	NNP	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	Cannabaceae	_	_	NNP	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	Gingeraceae	_	_	NNP	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	use	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	these	_	_	DT	_	_	_	_	_
5	essential	_	_	JJ	_	_	_	_	_
6	oils	_	_	NNS	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	traditional	_	_	JJ	_	_	_	_	_
9	herbal	_	_	JJ	_	_	_	_	_
10	medicine	_	_	NN	_	_	_	_	_
11	such	_	_	JJ	_	_	_	_	_
12	as	_	_	IN	_	_	_	_	_
13	aromatherapy	_	_	NN	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	Ayurvedic	_	_	JJ	_	_	_	_	_
16	medicine	_	_	NN	_	_	_	_	_
17	is	_	_	VBZ	_	_	_	_	_
18	well	_	_	RB	_	_	_	_	_
19	documented	_	_	VBN	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	There	_	_	EX	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	currently	_	_	RB	_	_	_	_	_
4	little	_	_	JJ	_	_	_	_	_
5	evidence	_	_	NN	_	_	_	_	_
6	their	_	_	PRP$	_	_	_	_	_
7	use	_	_	NN	_	_	_	_	_
8	confers	_	_	VBZ	_	_	_	_	_
9	actual	_	_	JJ	_	_	_	_	_
10	medical	_	_	JJ	_	_	_	_	_
11	benefits	_	_	NNS	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	yet	_	_	CC	_	_	_	_	_
14	their	_	_	PRP$	_	_	_	_	_
15	use	_	_	NN	_	_	_	_	_
16	remains	_	_	VBZ	_	_	_	_	_
17	widespread	_	_	JJ	_	_	_	_	_
18	due	_	_	JJ	_	_	_	_	_
19	to	_	_	TO	_	_	_	_	_
20	their	_	_	PRP$	_	_	_	_	_
21	aesthetic	_	_	JJ	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	historical	_	_	JJ	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	and	_	_	CC	_	_	_	_	_
26	cultural	_	_	JJ	_	_	_	_	_
27	significance	_	_	NN	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	On	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	other	_	_	JJ	_	_	_	_	_
4	hand	_	_	NN	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	a	_	_	DT	_	_	_	_	_
7	number	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	highly	_	_	RB	_	_	_	_	_
10	functionalized	_	_	VBN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	non-volatile	_	_	JJ	_	_	_	_	_
13	sesquiterpenes	_	_	NNS	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	plant	_	_	NN	_	_	_	_	_
16	origin	_	_	NN	_	_	_	_	_
17	have	_	_	VBP	_	_	_	_	_
18	demonstrated	_	_	VBN	_	_	_	_	_
19	highly	_	_	RB	_	_	_	_	_
20	specific	_	_	JJ	_	_	_	_	_
21	biological	_	_	JJ	_	_	_	_	_
22	activity	_	_	NN	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	have	_	_	VBP	_	_	_	_	_
25	therefore	_	_	RB	_	_	_	_	_
26	been	_	_	VBN	_	_	_	_	_
27	investigated	_	_	VBN	_	_	_	_	_
28	for	_	_	IN	_	_	_	_	_
29	their	_	_	PRP$	_	_	_	_	_
30	clinical	_	_	JJ	_	_	_	_	_
31	potential	_	_	NN	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	A	_	_	DT	_	_	_	_	_
2	selection	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	these	_	_	DT	_	_	_	_	_
5	medically	_	_	RB	_	_	_	_	_
6	useful	_	_	JJ	_	_	_	_	_
7	plant	_	_	NN	_	_	_	_	_
8	sesquiterpenoids	_	_	NNS	_	_	_	_	_
9	follows	_	_	VBZ	_	_	_	_	_
10	.	_	_	.	_	_	_	_	_


1	4.1	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Artemisinin	_	_	NNP	_	_	_	_	_


1	Wormwood	_	_	NNP	_	_	_	_	_
2	(	_	_	-LRB-	_	_	_	_	_
3	Artemisia	_	_	NNP	_	_	_	_	_
4	annua	_	_	FW	_	_	_	_	_
5	L.	_	_	NNP	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	or	_	_	CC	_	_	_	_	_
8	qinghaosu	_	_	NNP	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	Asteraceae	_	_	NNP	_	_	_	_	_
11	)	_	_	-RRB-	_	_	_	_	_
12	is	_	_	VBZ	_	_	_	_	_
13	native	_	_	JJ	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	China	_	_	NNP	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	is	_	_	VBZ	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	source	_	_	NN	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	the	_	_	DT	_	_	_	_	_
22	sesquiterpene	_	_	NN	_	_	_	_	_
23	endoperoxide	_	_	NN	_	_	_	_	_
24	artemisinin	_	_	NN	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	shown	_	_	VBN	_	_	_	_	_
27	to	_	_	TO	_	_	_	_	_
28	be	_	_	VB	_	_	_	_	_
29	highly	_	_	RB	_	_	_	_	_
30	effective	_	_	JJ	_	_	_	_	_
31	at	_	_	IN	_	_	_	_	_
32	treating	_	_	VBG	_	_	_	_	_
33	malaria	_	_	NN	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	early	_	_	JJ	_	_	_	_	_
4	1970s	_	_	NNS	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	phytochemists	_	_	NNS	_	_	_	_	_
7	such	_	_	JJ	_	_	_	_	_
8	as	_	_	IN	_	_	_	_	_
9	Youyou	_	_	NNP	_	_	_	_	_
10	Tu	_	_	NNP	_	_	_	_	_
11	investigated	_	_	VBD	_	_	_	_	_
12	plants	_	_	NNS	_	_	_	_	_
13	used	_	_	VBN	_	_	_	_	_
14	in	_	_	IN	_	_	_	_	_
15	traditional	_	_	JJ	_	_	_	_	_
16	Chinese	_	_	JJ	_	_	_	_	_
17	herbal	_	_	JJ	_	_	_	_	_
18	medicine	_	_	NN	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	identified	_	_	VBD	_	_	_	_	_
21	the	_	_	DT	_	_	_	_	_
22	usefulness	_	_	NN	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	traditional	_	_	JJ	_	_	_	_	_
26	remedy	_	_	NN	_	_	_	_	_
27	qinghaosu	_	_	NN	_	_	_	_	_
28	in	_	_	IN	_	_	_	_	_
29	eradicating	_	_	VBG	_	_	_	_	_
30	Plasmodium	_	_	NNP	_	_	_	_	_
31	spp	_	_	NNP	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_
33	infections	_	_	NNS	_	_	_	_	_
34	,	_	_	,	_	_	_	_	_
35	the	_	_	DT	_	_	_	_	_
36	causative	_	_	JJ	_	_	_	_	_
37	agent	_	_	NN	_	_	_	_	_
38	of	_	_	IN	_	_	_	_	_
39	malaria	_	_	NN	_	_	_	_	_
40	,	_	_	,	_	_	_	_	_
41	for	_	_	IN	_	_	_	_	_
42	which	_	_	WDT	_	_	_	_	_
43	she	_	_	PRP	_	_	_	_	_
44	received	_	_	VBD	_	_	_	_	_
45	a	_	_	DT	_	_	_	_	_
46	Nobel	_	_	NNP	_	_	_	_	_
47	Prize	_	_	NNP	_	_	_	_	_
48	in	_	_	IN	_	_	_	_	_
49	Medicine	_	_	NNP	_	_	_	_	_
50	in	_	_	IN	_	_	_	_	_
51	2015	_	_	CD	_	_	_	_	_
52	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	more	_	_	RBR	_	_	_	_	_
4	effective	_	_	JJ	_	_	_	_	_
5	against	_	_	IN	_	_	_	_	_
6	a	_	_	DT	_	_	_	_	_
7	broader	_	_	JJR	_	_	_	_	_
8	range	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	life	_	_	NN	_	_	_	_	_
11	cycle	_	_	NN	_	_	_	_	_
12	stages	_	_	NNS	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	apicomplexan	_	_	JJ	_	_	_	_	_
16	parasite	_	_	NN	_	_	_	_	_
17	than	_	_	IN	_	_	_	_	_
18	traditional	_	_	JJ	_	_	_	_	_
19	anti-malarials	_	_	NNS	_	_	_	_	_
20	such	_	_	JJ	_	_	_	_	_
21	as	_	_	IN	_	_	_	_	_
22	quinine	_	_	NN	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	Artemisinin	_	_	NNP	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	a	_	_	DT	_	_	_	_	_
4	sesquiterpene	_	_	NN	_	_	_	_	_
5	lactone	_	_	NN	_	_	_	_	_
6	with	_	_	IN	_	_	_	_	_
7	an	_	_	DT	_	_	_	_	_
8	unusual	_	_	JJ	_	_	_	_	_
9	endoperoxide	_	_	NN	_	_	_	_	_
10	ring	_	_	NN	_	_	_	_	_
11	which	_	_	WDT	_	_	_	_	_
12	imparts	_	_	VBZ	_	_	_	_	_
13	its	_	_	PRP$	_	_	_	_	_
14	anti-malarial	_	_	JJ	_	_	_	_	_
15	properties	_	_	NNS	_	_	_	_	_
16	(	_	_	-LRB-	_	_	_	_	_
17	Figure	_	_	NN	_	_	_	_	_
18	6	_	_	CD	_	_	_	_	_
19	)	_	_	-RRB-	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	mechanism	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	action	_	_	NN	_	_	_	_	_
5	is	_	_	VBZ	_	_	_	_	_
6	still	_	_	RB	_	_	_	_	_
7	unclear	_	_	JJ	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	several	_	_	JJ	_	_	_	_	_
11	possibilities	_	_	NNS	_	_	_	_	_
12	have	_	_	VBP	_	_	_	_	_
13	been	_	_	VBN	_	_	_	_	_
14	proposed	_	_	VBN	_	_	_	_	_
15	.	_	_	.	_	_	_	_	_


1	Most	_	_	JJS	_	_	_	_	_
2	involve	_	_	VBP	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	degradation	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	endoperoxide	_	_	NN	_	_	_	_	_
8	bridge	_	_	NN	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	a	_	_	DT	_	_	_	_	_
11	heme-dependent	_	_	JJ	_	_	_	_	_
12	process	_	_	NN	_	_	_	_	_
13	to	_	_	TO	_	_	_	_	_
14	form	_	_	VB	_	_	_	_	_
15	carbon	_	_	NN	_	_	_	_	_
16	centered	_	_	VBN	_	_	_	_	_
17	radicals	_	_	NNS	_	_	_	_	_
18	which	_	_	WDT	_	_	_	_	_
19	then	_	_	RB	_	_	_	_	_
20	alkylate	_	_	VBP	_	_	_	_	_
21	multiple	_	_	JJ	_	_	_	_	_
22	targets	_	_	NNS	_	_	_	_	_
23	including	_	_	VBG	_	_	_	_	_
24	heme	_	_	NN	_	_	_	_	_
25	and	_	_	CC	_	_	_	_	_
26	proteins	_	_	NNS	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	involvement	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	heme	_	_	NN	_	_	_	_	_
5	is	_	_	VBZ	_	_	_	_	_
6	consistent	_	_	JJ	_	_	_	_	_
7	with	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	specificity	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	artemisinin	_	_	NN	_	_	_	_	_
12	towards	_	_	IN	_	_	_	_	_
13	Plasmodium	_	_	NNP	_	_	_	_	_
14	spp	_	_	NN	_	_	_	_	_
15	.	_	_	.	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	direct	_	_	JJ	_	_	_	_	_
3	cause	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	toxicity	_	_	NN	_	_	_	_	_
6	to	_	_	TO	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	parasite	_	_	NN	_	_	_	_	_
9	is	_	_	VBZ	_	_	_	_	_
10	unclear	_	_	JJ	_	_	_	_	_
11	but	_	_	CC	_	_	_	_	_
12	may	_	_	MD	_	_	_	_	_
13	involve	_	_	VB	_	_	_	_	_
14	interference	_	_	NN	_	_	_	_	_
15	with	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	conversion	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	heme	_	_	NN	_	_	_	_	_
20	to	_	_	TO	_	_	_	_	_
21	hemozoin	_	_	NN	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	although	_	_	IN	_	_	_	_	_
24	this	_	_	DT	_	_	_	_	_
25	hypothesis	_	_	NN	_	_	_	_	_
26	has	_	_	VBZ	_	_	_	_	_
27	been	_	_	VBN	_	_	_	_	_
28	disputed	_	_	VBN	_	_	_	_	_
29	(	_	_	-LRB-	_	_	_	_	_
30	and	_	_	CC	_	_	_	_	_
31	reviewed	_	_	VBN	_	_	_	_	_
32	in	_	_	IN	_	_	_	_	_
33	reference	_	_	NN	_	_	_	_	_
34	)	_	_	-RRB-	_	_	_	_	_
35	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	early	_	_	JJ	_	_	_	_	_
3	stages	_	_	NNS	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	artemisinin	_	_	NN	_	_	_	_	_
6	biosynthesis	_	_	NN	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	glandular	_	_	JJ	_	_	_	_	_
9	trichomes	_	_	NNS	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	A.	_	_	NNP	_	_	_	_	_
12	annua	_	_	NN	_	_	_	_	_
13	are	_	_	VBP	_	_	_	_	_
14	now	_	_	RB	_	_	_	_	_
15	understood	_	_	VBN	_	_	_	_	_
16	at	_	_	IN	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	biochemical	_	_	JJ	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	molecular	_	_	JJ	_	_	_	_	_
21	levels	_	_	NNS	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	although	_	_	IN	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	exact	_	_	JJ	_	_	_	_	_
26	mechanism	_	_	NN	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	the	_	_	DT	_	_	_	_	_
29	later	_	_	JJR	_	_	_	_	_
30	stages	_	_	NNS	_	_	_	_	_
31	remains	_	_	VBZ	_	_	_	_	_
32	unclear	_	_	JJ	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_


1	Current	_	_	JJ	_	_	_	_	_
2	efforts	_	_	NNS	_	_	_	_	_
3	now	_	_	RB	_	_	_	_	_
4	focus	_	_	VBP	_	_	_	_	_
5	on	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	regulation	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	this	_	_	DT	_	_	_	_	_
10	pathway	_	_	NN	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	an	_	_	DT	_	_	_	_	_
13	effort	_	_	NN	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	improve	_	_	VB	_	_	_	_	_
16	artemisinin	_	_	NN	_	_	_	_	_
17	production	_	_	NN	_	_	_	_	_
18	directly	_	_	RB	_	_	_	_	_
19	in	_	_	IN	_	_	_	_	_
20	plants	_	_	NNS	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	pathway	_	_	NN	_	_	_	_	_
3	begins	_	_	VBZ	_	_	_	_	_
4	with	_	_	IN	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	conversion	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	FDP	_	_	NNP	_	_	_	_	_
9	to	_	_	TO	_	_	_	_	_
10	amorpha-4,11-diene	_	_	NN	_	_	_	_	_
11	by	_	_	IN	_	_	_	_	_
12	amorpha-4,11-diene	_	_	NN	_	_	_	_	_
13	synthase	_	_	NN	_	_	_	_	_
14	(	_	_	-LRB-	_	_	_	_	_
15	Figure	_	_	NN	_	_	_	_	_
16	6	_	_	CD	_	_	_	_	_
17	)	_	_	-RRB-	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	Biochemical	_	_	JJ	_	_	_	_	_
2	characterization	_	_	NN	_	_	_	_	_
3	and	_	_	CC	_	_	_	_	_
4	metabolite	_	_	NN	_	_	_	_	_
5	profiling	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	plant	_	_	NN	_	_	_	_	_
8	tissue	_	_	NN	_	_	_	_	_
9	indicated	_	_	VBD	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	presence	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	this	_	_	DT	_	_	_	_	_
14	olefin	_	_	NN	_	_	_	_	_
15	as	_	_	RB	_	_	_	_	_
16	well	_	_	RB	_	_	_	_	_
17	as	_	_	IN	_	_	_	_	_
18	its	_	_	PRP$	_	_	_	_	_
19	oxygenated	_	_	JJ	_	_	_	_	_
20	derivatives	_	_	NNS	_	_	_	_	_
21	artemisinic	_	_	JJ	_	_	_	_	_
22	alcohol	_	_	NN	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	aldehyde	_	_	NN	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	dihydroartemisinic	_	_	JJ	_	_	_	_	_
27	alcohol	_	_	NN	_	_	_	_	_
28	and	_	_	CC	_	_	_	_	_
29	aldehyde	_	_	NN	_	_	_	_	_
30	,	_	_	,	_	_	_	_	_
31	and	_	_	CC	_	_	_	_	_
32	dihydroartemisinic	_	_	JJ	_	_	_	_	_
33	acid	_	_	NN	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_


1	Following	_	_	VBG	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	cloning	_	_	NN	_	_	_	_	_
4	and	_	_	CC	_	_	_	_	_
5	expression	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	CYP71AV1	_	_	NN	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	which	_	_	WDT	_	_	_	_	_
10	converts	_	_	VBZ	_	_	_	_	_
11	amorpha-4,11-diene	_	_	NN	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	artemisinic	_	_	JJ	_	_	_	_	_
14	alcohol	_	_	NN	_	_	_	_	_
15	and	_	_	CC	_	_	_	_	_
16	aldehyde	_	_	NN	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	Zhang	_	_	NNP	_	_	_	_	_
19	et	_	_	FW	_	_	_	_	_
20	al.	_	_	FW	_	_	_	_	_
21	characterized	_	_	VBD	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	artemisinic	_	_	JJ	_	_	_	_	_
24	aldehyde	_	_	NN	_	_	_	_	_
25	Δ11(13	_	_	CD	_	_	_	_	_
26	)	_	_	-RRB-	_	_	_	_	_
27	reductase	_	_	NN	_	_	_	_	_
28	(	_	_	-LRB-	_	_	_	_	_
29	Double	_	_	JJ	_	_	_	_	_
30	bond	_	_	NN	_	_	_	_	_
31	reductase	_	_	NN	_	_	_	_	_
32	2	_	_	CD	_	_	_	_	_
33	,	_	_	,	_	_	_	_	_
34	Dbr2	_	_	NNP	_	_	_	_	_
35	)	_	_	-RRB-	_	_	_	_	_
36	,	_	_	,	_	_	_	_	_
37	which	_	_	WDT	_	_	_	_	_
38	preferentially	_	_	RB	_	_	_	_	_
39	reduces	_	_	VBZ	_	_	_	_	_
40	artemisinic	_	_	JJ	_	_	_	_	_
41	aldehyde	_	_	NN	_	_	_	_	_
42	to	_	_	TO	_	_	_	_	_
43	dihydroartemisinic	_	_	JJ	_	_	_	_	_
44	aldehyde	_	_	NN	_	_	_	_	_
45	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	substrate	_	_	NN	_	_	_	_	_
3	is	_	_	VBZ	_	_	_	_	_
4	then	_	_	RB	_	_	_	_	_
5	converted	_	_	VBN	_	_	_	_	_
6	to	_	_	TO	_	_	_	_	_
7	dihydroartemisinic	_	_	JJ	_	_	_	_	_
8	acid	_	_	NN	_	_	_	_	_
9	by	_	_	IN	_	_	_	_	_
10	aldehyde	_	_	NN	_	_	_	_	_
11	dehydrogenase	_	_	NN	_	_	_	_	_
12	1	_	_	CD	_	_	_	_	_
13	(	_	_	-LRB-	_	_	_	_	_
14	Aldh1	_	_	NNP	_	_	_	_	_
15	)	_	_	-RRB-	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	From	_	_	IN	_	_	_	_	_
2	dihydroartemisinic	_	_	JJ	_	_	_	_	_
3	acid	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	remaining	_	_	VBG	_	_	_	_	_
7	steps	_	_	NNS	_	_	_	_	_
8	involve	_	_	VBP	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	photooxidative	_	_	JJ	_	_	_	_	_
11	formation	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	endoperoxide	_	_	NN	_	_	_	_	_
15	ring	_	_	NN	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	details	_	_	NNS	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	this	_	_	DT	_	_	_	_	_
7	process	_	_	NN	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	such	_	_	JJ	_	_	_	_	_
10	as	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	potential	_	_	JJ	_	_	_	_	_
13	involvement	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	additional	_	_	JJ	_	_	_	_	_
16	enzyme	_	_	NN	_	_	_	_	_
17	activities	_	_	NNS	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	are	_	_	VBP	_	_	_	_	_
20	currently	_	_	RB	_	_	_	_	_
21	unclear	_	_	JJ	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_

